400 related articles for article (PubMed ID: 22282466)
1. The use and interpretation of competing risks regression models.
Dignam JJ; Zhang Q; Kocherginsky M
Clin Cancer Res; 2012 Apr; 18(8):2301-8. PubMed ID: 22282466
[TBL] [Abstract][Full Text] [Related]
2. Analysis and design of randomised clinical trials involving competing risks endpoints.
Tai BC; Wee J; Machin D
Trials; 2011 May; 12():127. PubMed ID: 21595883
[TBL] [Abstract][Full Text] [Related]
3. Cumulative incidence in competing risks data and competing risks regression analysis.
Kim HT
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
[TBL] [Abstract][Full Text] [Related]
4. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
[TBL] [Abstract][Full Text] [Related]
5. Estimating sample size in the presence of competing risks - Cause-specific hazard or cumulative incidence approach?
Tai BC; Chen ZJ; Machin D
Stat Methods Med Res; 2018 Jan; 27(1):114-125. PubMed ID: 26711503
[TBL] [Abstract][Full Text] [Related]
6. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
[TBL] [Abstract][Full Text] [Related]
7. The importance of censoring in competing risks analysis of the subdistribution hazard.
Donoghoe MW; Gebski V
BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
[TBL] [Abstract][Full Text] [Related]
8. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
Austin PC; Fine JP
Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
[TBL] [Abstract][Full Text] [Related]
9. Dealing with competing risks: testing covariates and calculating sample size.
Pintilie M
Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
[TBL] [Abstract][Full Text] [Related]
10. Flexible competing risks regression modeling and goodness-of-fit.
Scheike TH; Zhang MJ
Lifetime Data Anal; 2008 Dec; 14(4):464-83. PubMed ID: 18752067
[TBL] [Abstract][Full Text] [Related]
11. Semiparametric competing risks regression under interval censoring using the R package intccr.
Park J; Bakoyannis G; Yiannoutsos CT
Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
[TBL] [Abstract][Full Text] [Related]
12. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.
Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B
BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428
[TBL] [Abstract][Full Text] [Related]
13. Competing risk analyses: how are they different and why should you care?
Chappell R
Clin Cancer Res; 2012 Apr; 18(8):2127-9. PubMed ID: 22427347
[TBL] [Abstract][Full Text] [Related]
14. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
Beuscart JB; Pagniez D; Boulanger E; Lessore de Sainte Foy C; Salleron J; Frimat L; Duhamel A
BMC Nephrol; 2012 May; 13():31. PubMed ID: 22646159
[TBL] [Abstract][Full Text] [Related]
15. Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure.
Moreno-Betancur M; Rey G; Latouche A
Biometrics; 2015 Jun; 71(2):498-507. PubMed ID: 25761785
[TBL] [Abstract][Full Text] [Related]
16. A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data.
Zhang X; Zhang MJ; Fine J
Stat Med; 2011 Jul; 30(16):1933-51. PubMed ID: 21557288
[TBL] [Abstract][Full Text] [Related]
17. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
Austin PC; Lee DS; Fine JP
Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
[TBL] [Abstract][Full Text] [Related]
18. Competing risks and time-dependent covariates.
Cortese G; Andersen PK
Biom J; 2010 Feb; 52(1):138-58. PubMed ID: 20029852
[TBL] [Abstract][Full Text] [Related]
19. Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
Ohneberg K; Schumacher M; Beyersmann J
Stat Med; 2017 Nov; 36(27):4353-4363. PubMed ID: 28833435
[TBL] [Abstract][Full Text] [Related]
20. Choice and interpretation of statistical tests used when competing risks are present.
Dignam JJ; Kocherginsky MN
J Clin Oncol; 2008 Aug; 26(24):4027-34. PubMed ID: 18711194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
